Points to Consider in the Design and Submission of Human Somatic-Cell Gene Therapy Protocols
Recombinant DNA Technical Bulletin. 1986 Dec; 9(4): 221-242.
Advisory Committees; Confidentiality; Consent; Disclosure; DNA; Ethical Review; Ethics; Ethics Committees; Federal Government; Gene Therapy; Government; Government Regulation; Health; Human Experimentation; Information Dissemination; Informed Consent; Patients; Privacy; Public Health; Public Policy; Recombinant DNA Research; Regulation; Research; Research Ethics; Research Ethics Committees; Review; Review Committees; Risks and Benefits; Selection of Subjects; Standards;
Showing items related by title, author, creator and subject.
Recombinant DNA Research; Request for Public Comment on `Points to Consider in the Design and Submission of Human Somatic-Cell Gene Therapy Protocols' United States. Department of Health and Human Services. National Institutes of Health (1985-01-22)
Points to Consider in the Design and Submission of Human Somatic-Cell Gene Therapy Protocols September 29, 1986. 21 p. National Institutes of Health [NIH] (United States). Recombinant DNA Advisory Committee. Human Gene Therapy Subcommittee (1987)